Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-06 10:26 am Purchase |
2024-09-30 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Frazier Life Sciences IX L.P. | 1,587,527 4.200% |
170,370 (+12.02%) |
Filing History |
| 2023-09-05 3:11 pm Purchase |
2023-08-31 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Frazier Life Sciences IX L.P. | 6,226,392 13.400% |
1,815,285 (+41.15%) |
Filing History |
| 2023-06-15 10:25 am Sale |
2023-06-13 | 13D | Passage Bio, Inc. PASG |
Frazier Life Sciences IX L.P. | 2,543,698 4.700% |
-1,213,217 (-32.29%) |
Filing History |
| 2023-04-14 12:45 pm Purchase |
2023-04-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Frazier Life Sciences IX L.P. | 4,411,107 11.600% |
549,326 (+14.22%) |
Filing History |
| 2022-09-26 4:00 pm Purchase |
2022-09-22 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences IX L.P. | 8,424,772 21.500% |
203,448 (+2.47%) |
Filing History |
| 2022-08-16 12:20 pm Purchase |
2022-08-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Frazier Life Sciences IX L.P. | 3,861,781 10.500% |
294,869 (+8.27%) |
Filing History |
| 2022-08-15 11:29 am Sale |
2022-08-11 | 13D | Passage Bio, Inc. PASG |
Frazier Life Sciences IX L.P. | 3,756,915 6.900% |
-1,264,523 (-25.18%) |
Filing History |
| 2022-08-11 3:55 pm Purchase |
2022-08-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences IX L.P. | 8,221,324 21.000% |
2,377,400 (+40.68%) |
Filing History |
| 2022-01-28 2:09 pm Sale |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Frazier Life Sciences IX L.P. | 1,417,157 6.900% |
-500,000 (-26.08%) |
Filing History |
| 2021-02-04 4:35 pm Unchanged |
2020-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Frazier Life Sciences IX L.P. | 895,000 4.500% |
0 (Unchanged) |
Filing History |
| 2021-01-27 2:56 pm Purchase |
2021-01-26 | 13D | Passage Bio, Inc. PASG |
Frazier Life Sciences IX L.P. | 5,021,438 9.500% |
12,219 (+0.24%) |
Filing History |
| 2020-12-23 1:08 pm Unchanged |
2020-12-21 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences IX L.P. | 5,843,924 18.700% |
0 (Unchanged) |
Filing History |
| 2020-12-18 12:40 pm Unchanged |
2020-12-17 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Frazier Life Sciences IX L.P. | 3,566,912 12.200% |
0 (Unchanged) |
Filing History |
| 2020-10-23 1:40 pm Purchase |
2020-10-20 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Frazier Life Sciences IX L.P. | 1,917,157 9.500% |
1,917,157 (New Position) |
Filing History |
| 2020-06-16 7:37 pm Sale |
2020-06-12 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences IX L.P. | 5,843,924 20.200% |
-1,440,345 (-19.77%) |
Filing History |